Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1991 2
1994 3
1995 1
1997 2
1998 3
2000 2
2001 1
2002 1
2003 1
2004 1
2005 2
2006 1
2007 2
2008 4
2010 2
2011 2
2012 3
2013 5
2014 7
2015 4
2016 2
2017 8
2018 7
2019 7
2020 12
2021 11
2022 18
2023 12
2024 9
2025 8
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20DL, 5BAuthor
Page 1
Acute rehabilitation following traumatic anterior shoulder dislocation (ARTISAN): pragmatic, multicentre, randomised controlled trial.
Kearney RS, Ellard DR, Parsons H, Haque A, Mason J, Nwankwo H, Bradley H, Drew S, Modi C, Bush H, Torgerson D, Underwood M; The ARTISAN collaborators; ARTISAN collaborators. Kearney RS, et al. BMJ. 2024 Jan 17;384:e076925. doi: 10.1136/bmj-2023-076925. BMJ. 2024. PMID: 38233068 Free PMC article. Clinical Trial.
Secondary outcomes included the QuickDASH, EQ-5D-5L, and complications. RESULTS: 482 participants were recruited from 40 sites in the UK. 354 (73%) participants completed the primary outcome score (n=180 allocated to advice only, n=174 allocated to advice and physiotherapy …
Secondary outcomes included the QuickDASH, EQ-5D-5L, and complications. RESULTS: 482 participants were recruited from 40 sites in the …
Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial.
Ospel JM, Dowlatshahi D, Demchuk A, Volders D, Möhlenbruch M, Nimjee S, Kennedy J, Buck B, Shankar JJ, Booth TC, Jumaa MA, Fahed R, Ganesh A, Zhang Q, Doram C, Ryckborst KJ, Hill MD, Goyal M; ESCAPE-MeVO investigators. Ospel JM, et al. Int J Stroke. 2024 Oct;19(9):1064-1070. doi: 10.1177/17474930241262642. Epub 2024 Jun 20. Int J Stroke. 2024. PMID: 38845180 Free PMC article. Clinical Trial.
Secondary outcomes include dichotomizations of the modified Rankin Score at 90 days, 24 h National Institutes of Health Stroke Score, difference between 24 h and baseline National Institutes of Health Stroke Score, mortality at 90 days, health-related quality of life (EQ-5D …
Secondary outcomes include dichotomizations of the modified Rankin Score at 90 days, 24 h National Institutes of Health Stroke Score, differ …
Astigmatic traction force microscopy (aTFM).
Li D, Colin-York H, Barbieri L, Javanmardi Y, Guo Y, Korobchevskaya K, Moeendarbary E, Li D, Fritzsche M. Li D, et al. Nat Commun. 2021 Apr 12;12(1):2168. doi: 10.1038/s41467-021-22376-w. Nat Commun. 2021. PMID: 33846322 Free PMC article.
Here, by performing traction force microscopy using fast single-frame astigmatic imaging coupled with total internal reflection fluorescence microscopy we improve the temporal resolution of three-dimensional mechanical force quantification up to 10-fold compared to its related su …
Here, by performing traction force microscopy using fast single-frame astigmatic imaging coupled with total internal reflection fluorescence …
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy.
Carullo G, Orsini N, Piano I, Pozzetti L, Papa A, Fontana A, Napoli D, Corsi F, Marco BD, Galante A, Marotta L, Panzeca G, O'Brien J, Sanchez AG, Doherty H, Mahon N, Clarke L, Contri C, Pasquini S, Gorelli B, Saponara S, Valoti M, Vincenzi F, Varani K, Ramunno A, Brogi S, Butini S, Gemma S, Kennedy BN, Gargini C, Strettoi E, Campiani G. Carullo G, et al. J Med Chem. 2024 Sep 12;67(17):14946-14973. doi: 10.1021/acs.jmedchem.4c00477. Epub 2024 Jul 4. J Med Chem. 2024. PMID: 38961727
We developed new HDAC inhibitors (5a-p), typified by a tetrahydro-gamma-carboline scaffold, characterized by high HDAC6 inhibition potency with balanced physicochemical properties for in vivo studies. Compound 5d (repistat, IC(50) HDAC6 = 6.32 nM) increased the levels of a …
We developed new HDAC inhibitors (5a-p), typified by a tetrahydro-gamma-carboline scaffold, characterized by high HDAC6 inhibition potency w …
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Taylor PC, Bieber T, Alten R, Witte T, Galloway J, Deberdt W, Issa M, Haladyj E, De La Torre I, Grond S, Wollenberg A. Taylor PC, et al. Adv Ther. 2023 Apr;40(4):1867-1883. doi: 10.1007/s12325-023-02445-w. Epub 2023 Feb 20. Adv Ther. 2023. PMID: 36802049 Free PMC article. Clinical Trial.
Incidence rates (IR) per 100 patient-years of major adverse cardiovascular event (MACE), malignancy, venous thromboembolism (VTE), serious infection, and mortality were calculated for patients with low risk (younger than 65 years with no specified risk factors), and patients at r …
Incidence rates (IR) per 100 patient-years of major adverse cardiovascular event (MACE), malignancy, venous thromboembolism (VTE), serious i …
In Regard to Shortall et al.
Ebert MA, Marcello M, Kennedy A, Haworth A, Holloway LC, Greer P, Dowling JA, Jameson MG, Roach D, Joseph DJ, Gulliford SL, Sydes MR, Hall E, Dearnaley DP. Ebert MA, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):831-833. doi: 10.1016/j.ijrobp.2021.10.140. Int J Radiat Oncol Biol Phys. 2022. PMID: 35101196 No abstract available.
Quality of life in Barth syndrome.
Kim AY, Vernon H, Manuel R, Almuqbil M, Hornby B. Kim AY, et al. Ther Adv Rare Dis. 2022 Jun 11;3:26330040221093743. doi: 10.1177/26330040221093743. eCollection 2022 Jan-Dec. Ther Adv Rare Dis. 2022. PMID: 37180415 Free PMC article.
METHODS: In this study, we characterize HRQoL in boys and men with BTHS through cross-sectional analysis of a variety of outcome measures including the Pediatric Quality of Life Inventory (PedsQL(TM)) Version 4.0 Generic Core Scales, PedsQL(TM) Multidimensional Fatigue Scale, Bar …
METHODS: In this study, we characterize HRQoL in boys and men with BTHS through cross-sectional analysis of a variety of outcome measures in …
The NEON (Nerve rEpair Or Not) trial: a randomized controlled trial of microsurgical repair versus nerve alignment for digital nerve injury.
Wormald JCR, Gardiner MD, Jerosch-Herold C, Cook J, Pinedo Villanueva R, O'Hanlon C, Vides N, Fabiano G, Parsons S, Davies L, Fletcher H, Glaze M, Cooper C, Power D, Jain A, Beard D; NEON study group. Wormald JCR, et al. Br J Surg. 2025 Sep 2;112(9):znaf174. doi: 10.1093/bjs/znaf174. Br J Surg. 2025. PMID: 40905509 Free PMC article. Clinical Trial.
There were also no differences in all secondary outcome measures, including Patient Evaluation Measure and EQ-5D-5L scores at 12 months. Complications were similar at 6 weeks and 12 months. The trial was closed early by the funder owing to slow recruitment and did not reac …
There were also no differences in all secondary outcome measures, including Patient Evaluation Measure and EQ-5D-5L scores at 12 mont …
Water-soluble vitamins and trace elements in children with chronic kidney disease stage 5d.
Huang HX, Hobson K, Benedetti C, Kennedy S. Huang HX, et al. Pediatr Nephrol. 2024 May;39(5):1405-1419. doi: 10.1007/s00467-023-06132-4. Epub 2023 Sep 12. Pediatr Nephrol. 2024. PMID: 37698654 Review.
Children receiving maintenance dialysis (chronic kidney disease (CKD) stage 5d) have unique risk factors for micronutrient deficiency or toxicity. Children receiving chronic dialysis often require specialized diet plans that may provide more than the recommended daily allo …
Children receiving maintenance dialysis (chronic kidney disease (CKD) stage 5d) have unique risk factors for micronutrient deficiency …
130 results